Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Inspire Medical Systems Raises FY2025 GAAP EPS Guidance from $0.40-$0.50 to $0.90-$1.00 vs $0.45 Est; Affirms FY2025 Sales Guidance of $900.000M-$910.000M vs $903.814M Est

Author: Benzinga Newsdesk | November 03, 2025 04:03pm
Inspire Medical Systems (NYSE:INSP) raises FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.90-$1.00 vs $0.45 analyst estimate. Affirms FY2025 sales outlook from $900.000 million-$910.000 million to $900.000 million-$910.000 million vs $903.814 million estimate.

Posted In: INSP


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist